General Statement of Disclosure:

CONSULTING FEES/HONORARIA: Novartis Corporation(MODEST), Esperion(MODEST), AstraZeneca Pharmaceuticals(MODEST), Amarin(MODEST), Bayer Healthcare Pharmaceuticals(MODEST), Boehringer Ingelheim Pharmaceuticals, Inc(MODEST), Novo Nordisk Inc.(MODEST), Pfizer Inc(MODEST)

View Full Disclosure